Cite
HARVARD Citation
Tilly, H. et al. (2019). Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study. Lancet oncology. 20 (7), pp. 998-1010. [Online].